Aquestive Therapeutics

AQST

Market cap $758M

6.21 USD

-0.11

1.74%

At close Updated Dec 12, 4:00 PM EST

Pre-market

After hours

6.36

+0.15

2.42%

1 day

-1.74%

5 days

-3.42%

1 month

11.29%

3 months

22.97%

6 months

87.61%

Year to date

69.21%

1 year

68.29%

5 years

-17.97%

10 years

-61.31%

About: Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

Employees: 142

Healthcare Drug Manufacturers - Specialty & Generic